CVE-2026-134262: admidio · Cross-site Scripting
Affects admidioSource CVE Database V5
Not known to be exploited · CVSS 9.2 Critical : upgrade to 5.0.18 as a priority.
Data as of 21 Nov 2026, 17:32 UTC
Thin evidence
One scorer or none| CNA (VulnCheck) | CVSS 4.0 | 9.2 |
|---|---|---|
| CNA (VulnCheck) | CVSS 3.1 | 8.1 |
- Patch
- Available – fixed in 5.0.18
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:H/VI:H/VA:N/SC:H/SI:H/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 21 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.
What to do
Upgrade admidio to 5.0.18.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Admidioadmidio | Affected
| Fixed in
|
AI-suggested
Upgrade Admidio to version 5.0.18 or later, where this vulnerability is fixed. No other mitigation is required as the fix addresses the root cause.
Description
Admidio versions 5.0.0 through 5.0.17 contain a stored cross-site scripting (XSS) vulnerability. This flaw allows role administrators to inject malicious JavaScript code into role names, which are rendered without proper encoding in a profile page attribute. When a full administrator views the affected profile page, the injected script can execute, enabling theft of the CSRF token and unauthorized assignment of the Administrator role. The vulnerability is fixed in version 5.0.18.